AT9283, a potent inhibitor of the Aurora kinases and Jak2, has therapeutic potential in myeloproliferative disorders
- DOI
- 10.1111/j.1365-2141.2010.08175.x
- Published
- 2010-06-09
- Container
- British Journal of Haematology
- Publisher
- Wiley
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1111/j.1365-2141.2010.08175.x,
title = {AT9283, a potent inhibitor of the Aurora kinases and Jak2, has therapeutic potential in myeloproliferative disorders},
author = {Mark A. Dawson and Jayne E. Curry and Kelly Barber and Philip A. Beer and Brent Graham and John F. Lyons and Caroline J. Richardson and Mike A. Scott and Tomoko Smyth and Matthew S. Squires and Neil T. Thompson and Anthony R. Green and Nicola G. Wallis},
year = {2010},
journal = {British Journal of Haematology},
doi = {10.1111/j.1365-2141.2010.08175.x},
url = {https://doi.org/10.1111/j.1365-2141.2010.08175.x}
}RIS
TY - JOUR TI - AT9283, a potent inhibitor of the Aurora kinases and Jak2, has therapeutic potential in myeloproliferative disorders AU - Mark A. Dawson AU - Jayne E. Curry AU - Kelly Barber AU - Philip A. Beer AU - Brent Graham AU - John F. Lyons AU - Caroline J. Richardson AU - Mike A. Scott AU - Tomoko Smyth AU - Matthew S. Squires AU - Neil T. Thompson AU - Anthony R. Green AU - Nicola G. Wallis PY - 2010 JO - British Journal of Haematology DO - 10.1111/j.1365-2141.2010.08175.x UR - https://doi.org/10.1111/j.1365-2141.2010.08175.x ER -
APA
Dawson, M. A., Curry, J. E., Barber, K., Beer, P. A., Graham, B., Lyons, J. F., Richardson, C. J., Scott, M. A., Smyth, T., Squires, M. S., Thompson, N. T., Green, A. R., & Wallis, N. G. (2010). AT9283, a potent inhibitor of the Aurora kinases and Jak2, has therapeutic potential in myeloproliferative disorders. British Journal of Haematology. https://doi.org/10.1111/j.1365-2141.2010.08175.x
Source records
- crossref · retrieved 2026-09-26T19:48:54.873Z